Growth Metrics

Electromed (ELMD) EBIAT (2016 - 2025)

Electromed (ELMD) has disclosed EBIAT for 16 consecutive years, with $2.8 million as the latest value for Q4 2025.

  • Quarterly EBIAT rose 40.29% to $2.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.0 million through Dec 2025, up 32.96% year-over-year, with the annual reading at $7.5 million for FY2025, 46.35% up from the prior year.
  • EBIAT for Q4 2025 was $2.8 million at Electromed, up from $2.1 million in the prior quarter.
  • The five-year high for EBIAT was $2.8 million in Q4 2025, with the low at $81000.0 in Q3 2022.
  • Average EBIAT over 5 years is $1.2 million, with a median of $1.1 million recorded in 2023.
  • The sharpest move saw EBIAT crashed 81.55% in 2022, then skyrocketed 850.97% in 2024.
  • Over 5 years, EBIAT stood at $838000.0 in 2021, then rose by 16.59% to $977000.0 in 2022, then surged by 71.34% to $1.7 million in 2023, then rose by 17.56% to $2.0 million in 2024, then skyrocketed by 40.29% to $2.8 million in 2025.
  • According to Business Quant data, EBIAT over the past three periods came in at $2.8 million, $2.1 million, and $2.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.